Lumida
/CYTK
⌘K
Cytokinetics Inc

Cytokinetics Inc

CYTK
$73.77USD+0.20%+0.15 today

MARKET CAP

10.3B

P/E (TTM)

FWD P/E

DAY RANGE

$74 – $76

52W RANGE

$47
$88

AI Summary

Stalk
StalkMedium

CYTK remains under distribution pressure, with price rejecting at the 9- and 20-period EMAs and approaching its rising 200-day SMA. The active Post-Parabola Collapse pattern identifies mean-reversion eligibility, shifting the medium-term bias to bullish despite the short-term downtrend. However, tactical execution remains unfavorable until price can reclaim and accept above the short-term EMAs. Therefore, entries should be deferred ("Stalk") around the 200-day SMA support, awaiting a clear reversal signal.

  • Q2 revenue of $28.6M outperforms $17.1M forecast; MYQORZO nets $25.3M with 40% share
  • Cash and investments of ~$1.7B fund commercialization through early 2026
  • Q2 R&D spending rose to $112.6M, straining cash runway
Full analysis →

Buying

11

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY20.09 M1.71 B+3.55 M+57.0%0.03%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUY18.72 M1.59 B+1.19 M+38.1%1.05%
RI

Rtw Investments, LP

Q2 2026

BUY2.86 M243.81 M+140.84 K+35.9%2.08%
CA

Citadel Advisors LLC

Q2 2026

BUY1.97 M167.55 M+412.39 K+63.5%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.59 M139.15 M+685.09 K+144.5%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY1.59 M135.31 M+927.31 K+210.6%0.15%
WP

Woodline Partners LP

Q2 2026

SELL1.10 M93.77 M+-900.15 K-28.9%0.29%
FA

Fisher Asset Management, LLC

Q2 2026

SELL743.70 K63.36 M+-24.57 K+25.1%0.02%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL731.08 K62.28 M+-367.07 K-13.9%0.08%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL457.91 K39.01 M+-174.65 K-6.4%1.80%
JH

Janus Henderson Group Plc

Q1 2026

BUY564.24 K37.19 M+308.03 K+128.4%0.01%
CP

California Public Employees Retirement System

Q2 2026

BUY211.05 K17.98 M+12.52 K+37.4%0.01%
MM

Millennium Management LLC

Q2 2026

SELL209.82 K17.87 M+-117.04 K-17.0%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY161.90 K13.79 M+5.36 K+33.7%0.00%
MG

Man Group Plc

Q2 2026

BUY17.39 K1.48 M+6.93 K+114.9%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL11.89 K1.01 M+-37.07 K-68.6%0.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY3.18 K271.16 K+314.00+43.4%0.00%